Malignant Bone Neoplasm clinical trials
6 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases
- Mg OSTEOCRETE Post-Treatment Outcomes
- Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
- Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
- Insights Into Participating in Studies for Bone Cancer
- Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Malignant Bone Neoplasm” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.